ARCHIVES

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

This article is from The Cancer Letter archive.

Vol. 28 No. 31 | August 2, 2002

Download PDF Visit The Full Archive

Related Articles

Reauthorization Bill Ready For Senate Floor; Report to Panel Makes Clear Why Renewal Needed

April 22, 1988

GP Amendment To Waxman Bill Would Leave Dollar Levels The Same But would Drop Centers Line Item

August 5, 1983

House, Senate Committee Increase FDA Funding, Drop User Fees

August 4, 1989

Antman Is President Elect; Minorities More Likely To Get Worse Care, IOM Finds

April 12, 2002

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012